|
WO1997005131A1
(en)
|
1995-08-02 |
1997-02-13 |
J. Uriach & Cia. S.A. |
New carboxamides with antifungal activity
|
|
US6218387B1
(en)
|
1996-12-20 |
2001-04-17 |
Hoechst Aktiengesellschaft |
Vitronectin receptor anatagonists, their preparation and their use
|
|
US6723727B1
(en)
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
CA2533889A1
(en)
|
2003-08-15 |
2005-03-03 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
US7465746B2
(en)
|
2003-08-15 |
2008-12-16 |
Merck & Co., Inc. |
Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
|
|
US7112316B1
(en)
|
2005-08-08 |
2006-09-26 |
Uop Llc |
Process for preparing molecular sieves via continuous addition of nutrients
|
|
EP1984355A2
(en)
|
2006-02-16 |
2008-10-29 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
|
|
ATE505454T1
(de)
|
2007-09-20 |
2011-04-15 |
Amgen Inc |
1-(4-(4-benzylbenzamid)-benzyl)-azetidin-3- carboxylsäurederivate und entsprechende verbindungen als s1p-rezeptor-modulatoren zur behandlung von immunerkrankungen
|
|
AU2009225869B2
(en)
|
2008-03-18 |
2014-01-23 |
Merck Sharp & Dohme Llc |
Substituted 4-hydroxypyrimidine-5-carboxamides
|
|
WO2010120935A1
(en)
|
2009-04-15 |
2010-10-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2011113707A1
(en)
|
2010-03-17 |
2011-09-22 |
Exxonmobil Chemical Patents Inc. |
Plasticiser blends and compositions and articles made therefrom
|
|
CA2815131C
(en)
|
2010-10-20 |
2020-06-09 |
Gruenenthal Gmbh |
Substituted 6-amino-nicotinamides as kcnq2/3 modulators
|
|
WO2013049255A1
(en)
|
2011-09-26 |
2013-04-04 |
Vanderbilt University |
Substitued 5-(prop-1-yn-1-yl)picolinamide analogs as allosteric modulators of mglur5 receptors
|
|
TWI648274B
(zh)
|
2013-02-15 |
2019-01-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類 （二）
|
|
EA032355B1
(ru)
|
2013-12-24 |
2019-05-31 |
Онкотартис, Инк. |
Бензамидные и никотинамидные соединения и способы их применения
|
|
KR101555033B1
(ko)
|
2014-07-28 |
2015-09-23 |
충남대학교산학협력단 |
신규한 메타논 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물
|
|
KR101551313B1
(ko)
|
2014-07-28 |
2015-09-09 |
충남대학교산학협력단 |
신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물
|
|
RU2017109122A
(ru)
|
2014-08-21 |
2018-09-21 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Способы лечения с использованием гетероциклических амидов в качестве ингибиторов киназы
|
|
EP3224237B1
(en)
|
2014-12-24 |
2024-09-11 |
National Institute Of Biological Sciences, Beijing |
Necrosis inhibitors
|
|
UY36680A
(es)
|
2015-05-19 |
2016-12-30 |
Glaxosmithkline Ip Dev Ltd |
Amidas heterocíclicas como inhibidores de quinasa
|
|
RU2716136C2
(ru)
|
2015-07-02 |
2020-03-06 |
Ф. Хоффманн-Ля Рош Аг |
Бициклические лактамы и способы их применения
|
|
WO2017069279A1
(ja)
|
2015-10-23 |
2017-04-27 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN108602809B
(zh)
|
2015-12-04 |
2022-09-30 |
戴纳立制药公司 |
异噁唑烷衍生的受体相互作用蛋白激酶1(ripk 1)的抑制剂
|
|
US10961258B2
(en)
|
2015-12-21 |
2021-03-30 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides as kinase inhibitors
|
|
US9815850B2
(en)
|
2016-02-05 |
2017-11-14 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
EP3515447A4
(en)
|
2016-09-26 |
2020-05-27 |
Tufts University |
Uridine nucleoside derivatives, compositions and methods of use
|
|
LT3580220T
(lt)
|
2017-02-13 |
2021-12-27 |
Bristol-Myers Squibb Company |
Aminotriazolopiridinai, kaip kinazės inhibitoriai
|
|
DE102017211104B3
(de)
|
2017-06-29 |
2018-10-18 |
Bundesdruckerei Gmbh |
Verfahren und Vorrichtung zum Verifizieren eines elektrolumineszierenden Sicherheitsmerkmals in einem Wert- oder Sicherheitsdokument unter Ausnutzung von zusätzlicher Lichtstrahlung
|
|
CN111566103B
(zh)
*
|
2017-10-30 |
2023-06-23 |
百时美施贵宝公司 |
作为激酶抑制剂的氨基咪唑并吡嗪
|
|
US11618753B2
(en)
*
|
2018-01-26 |
2023-04-04 |
Bristol-Myers Squibb Company |
Aminopyrrolotriazines as kinase inhibitors
|
|
SI3788044T1
(sl)
|
2018-05-03 |
2023-12-29 |
Rigel Pharmaceuticals, Inc. |
Spojine, ki zavirajo RIP1 in postopki za njihovo izdelavo in uporabo
|
|
WO2020007234A1
(zh)
*
|
2018-07-02 |
2020-01-09 |
深圳市塔吉瑞生物医药有限公司 |
用于抑制蛋白激酶活性的炔基(杂)芳环类化合物
|
|
WO2020013531A1
(ko)
|
2018-07-10 |
2020-01-16 |
보로노이바이오 주식회사 |
N-(3-(이미다조[1,2-b]피리다진-3-일에티닐)-4-메틸페닐)-5-페닐-4,5-다이하이드로-1H-피라졸-1-카복사마이드 유도체 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물
|
|
WO2020149553A1
(ko)
*
|
2019-01-15 |
2020-07-23 |
주식회사 보로노이 |
아릴 또는 헤테로아릴 유도체, 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물
|
|
TW202321211A
(zh)
|
2021-08-10 |
2023-06-01 |
美商艾伯維有限公司 |
菸鹼醯胺ripk1抑制劑
|